Hepatic Subcapsular Hematoma after Dual Antiplatelet Therapy using Ticagrelor

Subcapsular liver hematoma is a rare life-threatening complication that may occur due to several causes such as coagulation disorder, neoplasm, pregnancy, trauma, and iatrogenic etiologies. However, the etiopathogenesis of spontaneous hematoma is still unclear. This condition is defined as an accumulation of blood between Glisson’s capsule and the liver parenchyma. Patients who undergo coronary intervention are vulnerable in terms of bleeding complication due to use of dual antiplatelet therapy (DAPT). Herein, we report a case of subacute hepatic subcapsular hematoma that occurred after percutaneous coronary intervention; the patient was receiving DAPT that included ticagrelor.